Efpeglenatide Glucagon-like peptide 1 (GLP-1) receptor agonist Treatment for type 2 diabetes

Reid, J; Rana, K; Segel, SA; Sheikh-Ali, M; Choksi, RR; Goldfaden, RF

Goldfaden, RF (reprint author), East Coast Inst Res, Jacksonville, FL 32216 USA.

DRUGS OF THE FUTURE, 2019; 44 (6): 435